Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$11.6B |
| 2 |
NVIDIA
NVDA
|
+$4.91B |
| 3 |
Microsoft
MSFT
|
+$4.44B |
| 4 |
Amazon
AMZN
|
+$3.61B |
| 5 |
Visa
V
|
+$2.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$1.81B |
| 2 |
Applovin
APP
|
+$1.68B |
| 3 |
Palantir
PLTR
|
+$1.32B |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$1.23B |
| 5 |
Marvell Technology
MRVL
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.5% |
| 2 | Financials | 13.58% |
| 3 | Consumer Discretionary | 10.94% |
| 4 | Healthcare | 10% |
| 5 | Industrials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
United-Guardian
UG
$32.4M
| $1.33M | ﹤0.01% |
137,356
| – | – |
|
3677
Verrica Pharmaceuticals
VRCA
$89.7M
| $1.32M | ﹤0.01% |
187,991
+59,331
| +46% | +$652K |
|
3678
VirnetX Holding Corp
VHC
$54.4M
| $1.32M | ﹤0.01% |
167,522
| – | – |
|
3679
MediciNova
MNOV
$65.5M
| $1.31M | ﹤0.01% |
623,333
| – | – |
|
3680
Ampco-Pittsburgh
AP
$163M
| $1.31M | ﹤0.01% |
624,432
| – | – |
|
3681
Landmark Bancorp
LARK
$191M
| $1.3M | ﹤0.01% |
57,027
| – | – |
|
3682
MIND Technology
MIND
$45.3M
| $1.3M | ﹤0.01% |
163,795
+152,364
| +1,333% | +$686K |
|
3683
CVD Equipment Corp
CVV
$50M
| $1.29M | ﹤0.01% |
293,410
-11,525
| -4% | -$38.2K |
|
3684
Schwab US Broad Market ETF
SCHB
$43.2B
| $1.29M | ﹤0.01% |
56,769
+9,129
| +19% | +$209K |
|
3685
Prelude Therapeutics
PRLD
$366M
| $1.29M | ﹤0.01% |
1,010,392
-11,378
| -1% | -$15.1K |
|
3686
AMCON Distributing
DIT
$61.1M
| $1.28M | ﹤0.01% |
15,038
| – | – |
|
3687
ADC Therapeutics
ADCT
$134M
| $1.28M | ﹤0.01% |
644,618
+105,259
| +20% | +$275K |
|
3688
Duos Technologies
DUOT
$270M
| $1.28M | ﹤0.01% |
214,204
| – | – |
|
3689
IBEX
IBEX
$473M
| $1.28M | ﹤0.01% |
59,500
+133
| +0.2% | +$2.61K |
|
3690
Journey Medical
DERM
$175M
| $1.27M | ﹤0.01% |
325,171
| – | – |
|
3691
Kornit Digital
KRNT
$705M
| $1.27M | ﹤0.01% |
41,052
+4,177
| +11% | +$120K |
|
3692
GEN Restaurant Group
GENK
$10.9M
| $1.27M | ﹤0.01% |
169,371
| – | – |
|
3693
Fortress Biotech
FBIO
$104M
| $1.27M | ﹤0.01% |
625,054
| – | – |
|
|
NEUE
3694
DELISTED
NeueHealth
NEUE
| $1.24M | ﹤0.01% |
167,777
| – | – |
|
|
NIXX
3695
Nixxy Inc
NIXX
$15.4M
| $1.24M | ﹤0.01% |
+236,350
| New | +$783K |
|
3696
Monopar Therapeutics
MNPR
$726M
| $1.24M | ﹤0.01% |
+56,509
| New | +$948K |
|
3697
Avalo Therapeutics
AVTX
$965M
| $1.23M | ﹤0.01% |
165,801
+155,433
| +1,499% | +$1.66M |
|
3698
Noodles & Co
NDLS
$111M
| $1.23M | ﹤0.01% |
264,474
-6,250
| -2% | -$45.7K |
|
|
MAG
3699
DELISTED
MAG Silver
MAG
| $1.22M | ﹤0.01% |
90,123
+16,201
| +22% | +$252K |
|
|
AHT
3700
Ashford Hospitality Trust
AHT
$20.9M
| $1.22M | ﹤0.01% |
169,987
-2
| -0% | -$15 |
|
Similar funds
Vanguard Group's Q4 2024 Portfolio in Review
As of Q4 2024, Vanguard Group held 4,397 positions worth $5.74T, up 2.8% from $5.58T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.4%. Vanguard Group opened 46 new positions and exited 103, leaving the 4,397-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2024 buy was Primo Brands: 15,315,211 shares worth $471M.
- Vanguard Group added most to Apple in Q4 2024, an estimated $11.6B increase.
- Vanguard Group's biggest Q4 2024 reduction was Applovin, cutting an estimated $1.68B.
- Vanguard Group fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $1.81B.
- Vanguard Group's ten largest holdings make up 29% of its $5.74T portfolio in Q4 2024.
- Vanguard Group opened 46 new positions and closed 103 in Q4 2024.
- Vanguard Group's portfolio value rose 2.8% quarter-over-quarter to $5.74T.
Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.